Detalhe da pesquisa
1.
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.
Br J Cancer
; 120(9): 913-921, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30899086
2.
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
N Engl J Med
; 375(8): 717-29, 2016 Aug 25.
Artigo
Inglês
| MEDLINE | ID: mdl-27557300
3.
Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
Mod Pathol
; 30(4): 509-518, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28084333
4.
Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance.
Breast Cancer Res Treat
; 155(3): 463-9, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26820652
5.
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Lancet
; 384(9938): 164-72, 2014 Jul 12.
Artigo
Inglês
| MEDLINE | ID: mdl-24529560
6.
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Lancet Oncol
; 15(12): 1303-10, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25439688
7.
Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants.
Antivir Ther
; 28(1): 13596535231151626, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36691849
8.
A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults.
Antivir Ther
; 28(3): 13596535231172878, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37199270
9.
Radiotherapy or surgery for the axilla in node-positive breast cancer?--authors' reply.
Lancet Oncol
; 16(2): e54, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25638681
10.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adults.
Antivir Ther
; 26(3-5): 58-68, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35485332
11.
Surrogate marker analysis in cancer clinical trials through time-to-event mediation techniques.
Stat Methods Med Res
; 27(11): 3367-3385, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28425345
12.
Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: An analysis of the EORTC 10994/BIG 1-00 study.
Eur J Cancer
; 79: 226-234, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28527420
13.
Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumour suppressor in breast cancer.
Eur J Cancer
; 72: 95-102, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28027521
14.
Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
Eur J Cancer
; 82: 219-227, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28292559
15.
[Axillary lymph node dissection versus axillary radiotherapy in patients with a positive sentinel node: the AMAROS trial]. / Okselklierdissectie versus okselbestraling bij borstkankerpatiënten met een positieve schildwachtklier: de EORTC 10981 AMAROS-studie.
Ned Tijdschr Geneeskd
; 159: A9302, 2015.
Artigo
Holandês
| MEDLINE | ID: mdl-26488192
16.
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Eur J Cancer
; 51(12): 1497-510, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26025767